MAK Capital increases stake in Hapvida and declares financial investment purposes

MAK Capital Fund LP increased its shareholding in Hapvida and now holds 25,366,000 common shares, equivalent to approximately 5.05% of the health plan operator's capital. The data is contained in the company's market statement regarding correspondence received from the fund, according to Money Times.

Announcements of this type give the market the opportunity to monitor who enters the capital of a publicly traded company. In this case, the starting point is a correspondence sent to Hapvida itself, which the company brought to the attention of investors.

According to the correspondence, the declared purpose of the fund is financial investment. MAK did not set a predetermined number of shares to be acquired, which leaves the size of possible future purchases open.

According to the statement, the fund also does not aim to change Hapvida's control or corporate structure. For the minority shareholder, this is the central fact: the reading is one of investor participation, and not a dispute for command of the company.

The fund declared that it does not hold other securities or derivatives referenced in Hapvida shares and is not a party to voting agreements or the purchase and sale of company shares. Reported exposure, therefore, is limited to common shares.

What changes for the investor

For those who follow Hapvida, the statement does not indicate a change in governance or a sign of a dispute over control, as the fund has declared financial purposes and does not have a voting agreement with third parties. The practical effect will depend on future purchases, which have no defined quantity. New communications about participation will show whether the share continues to grow. This material does not constitute a recommendation to buy or sell shares.

Automatically translated from Portuguese.